Ontology highlight
ABSTRACT:
SUBMITTER: Amberg A
PROVIDER: S-EPMC7500704 | biostudies-literature | 2019 Mar
REPOSITORIES: biostudies-literature
Amberg Alexander A Andaya Roxanne V RV Anger Lennart T LT Barber Chris C Beilke Lisa L Bercu Joel J Bower Dave D Brigo Alessandro A Cammerer Zoryanna Z Cross Kevin P KP Custer Laura L Dobo Krista K Gerets Helga H Gervais Véronique V Glowienke Susanne S Gomez Stephen S Van Gompel Jacky J Harvey James J Hasselgren Catrin C Honma Masamitsu M Johnson Candice C Jolly Robert R Kemper Raymond R Kenyon Michelle M Kruhlak Naomi N Leavitt Penny P Miller Scott S Muster Wolfgang W Naven Russell R Nicolette John J Parenty Alexis A Powley Mark M Quigley Donald P DP Reddy M Vijayaraj MV Sasaki Jennifer C JC Stavitskaya Lidiya L Teasdale Andrew A Trejo-Martin Alejandra A Weiner Sandy S Welch Dennie S DS White Angela A Wichard Joerg J Woolley David D Myatt Glenn J GJ
Regulatory toxicology and pharmacology : RTP 20181215
The International Council for Harmonization (ICH) M7 guideline describes a hazard assessment process for impurities that have the potential to be present in a drug substance or drug product. In the absence of adequate experimental bacterial mutagenicity data, (Q)SAR analysis may be used as a test to predict impurities' DNA reactive (mutagenic) potential. However, in certain situations, (Q)SAR software is unable to generate a positive or negative prediction either because of conflicting informati ...[more]